Medication continuity during international dual diagnosis treatment needs a clinical plan and a lawful supply plan. The first explains who will review, prescribe, and monitor treatment. The second establishes what can be carried across each border, what documents are required, and how further supplies can be obtained. Resolve both before relying on an overseas admission date.
This guide helps organize questions for prescribers, pharmacists, the receiving provider, and official authorities. It does not recommend doses, substitutions, or a way to avoid medicine controls. Do not change treatment to fit a journey without advice from the clinician responsible for it.
Build one current medication record
Ask the current prescriber or pharmacist to help prepare an accurate list. Include each medicine’s generic and brand names, strength, formulation, prescribed schedule, and purpose where appropriate. Record who prescribes it and when the last review took place. Include nonprescription products and supplements so the receiving team can assess the complete picture.
Separate medicines currently taken from those stopped, considered, or prescribed previously. If a recent change has not yet been reflected in a letter or electronic record, ask for clarification. A list containing several historical doses without dates can leave the next clinician unsure which instruction is current.
Describe practical difficulties honestly, including missed doses, trouble obtaining refills, unwanted effects, or uncertainty about instructions. The aim is a usable clinical handover. If several professionals prescribe, ask who will reconcile their information and produce the version that travels with you.
Map the full route before checking rules
Write down the country of usual residence, departure country, destination, transit stops, and return route. Add the intended dates and the amount of medication the prescriber proposes you carry. If the itinerary changes, revisit any check that depended on the original route.
CDC advice on traveling abroad with medicine recommends checking destination and layover rules with the relevant embassies. Medicines available at home may have different legal status abroad. The practical implication is to ask about the exact medicine and itinerary, rather than assuming that a general statement about prescription drugs covers every product.
Check official medicine import or controlled-drug guidance for the jurisdictions involved, and ask the relevant authority if the published information does not resolve your circumstances. A program’s admissions team can help identify the right questions, but an informal assurance from a provider should not replace an official requirement.
Keep clinical, border, and dispensing questions distinct
| Question | Who can help answer it? | What to record |
|---|---|---|
| Is this the appropriate treatment for me? | The responsible prescriber and relevant clinical team | The agreed regimen, review needs, and reasons for any change |
| May I carry it on this route? | The relevant official border or medicines authority | Applicable permission, documents, quantities, and dates |
| Can it be prescribed at the destination? | A clinician authorized to practice there | Assessment requirements and the proposed prescribing arrangement |
| Can the exact product be supplied? | The receiving provider and an appropriate local pharmacy | Availability, ordering time, formulation, and dispensing process |
| Who will monitor treatment? | The prescribing and receiving clinical teams | Appointments, tests where required, and responsibility for reviewing results |
| What happens after I return? | The intended home prescriber and applicable authorities | Acceptance of the follow-up plan and lawful return arrangements |
An answer in one column does not settle all the others. Permission to carry a medicine does not ensure a local refill, and a pharmacy’s ability to stock it does not determine whether a new clinician will prescribe it for you.
A UK rule that needs particular care
Home Office guidance on traveling with controlled medicines distinguishes visitors carrying medicines prescribed in their country of habitual residence from UK residents receiving medical treatment abroad. It explicitly says the personal import policy does not apply to the latter group, including when controlled drugs are dispensed abroad.
A person habitually resident in the UK who is prescribed controlled drugs overseas and wants to return with them is directed to contact the Home Office. Do not apply a visitor’s supply allowance to that situation. Use the current official guidance and contact route to clarify the individual arrangement before travel.
This example shows why nationality alone is not a sufficient basis for a medicine check. Tell the relevant authority where you normally live, where the medicine was prescribed and dispensed, and why you are traveling. Other countries have their own rules; the UK distinction should not be generalized into a worldwide policy.
Ask who takes over prescribing during treatment
Have the receiving program identify the clinician who will assess medication needs and explain when that assessment occurs. Ask what information is needed beforehand and how the team communicates with the current prescriber. Establish what happens between arrival and the first full review.
If the program uses an external psychiatrist or pharmacy, clarify the arrangement and any additional fees. Ask who can answer a medication question outside the usual appointment schedule. The phrase “medical support available” needs to be translated into a practical route that the patient can actually use.
If a different medicine or formulation is proposed, ask the clinicians to discuss the reason, risks, monitoring, and transition plan directly. Do not infer equivalence from similar packaging or names. Our guide to medication coordination in co-occurring care explains how to keep decisions connected across professionals.
Prepare for supply interruptions without improvising
Discuss delays, lost luggage, a longer stay, and an unexpected change in treatment with the clinical team before departure. Ask how much supply is clinically appropriate and legally permitted, and how an emergency replacement would be arranged. Do not assume that someone can mail additional controlled medicine across a border.
Ask the provider whether it has confirmed availability with the intended pharmacy or is simply familiar with the medicine’s name. If ordering time matters, identify who will place the request and how the patient will know it is ready. An unconfirmed refill plan should remain an unresolved item in the travel decision.
For medicines requiring monitoring, ask where the relevant review or test can take place and who receives the results. Bring the most recent useful information in the form requested by the receiving team. A plan to obtain a test is incomplete if no professional has accepted responsibility for interpreting it.
Account for medicine given at appointments
If any treatment is administered by a clinician rather than taken independently, ask how the appointment schedule fits the trip. Identify where the next administration would occur, who has agreed to provide it, and what assessment or records they require. Discuss this with the current prescriber before assuming that a destination clinic can continue the same arrangement.
Include travel delays and an extended stay in that discussion. Ask which team you should contact if an appointment cannot happen as planned. Do not bring a product expecting a new professional to administer it without prior agreement, or alter the interval yourself to accommodate the itinerary.
Make the travel-day instructions understandable
The CDC advises keeping medicines in their original labeled containers and carrying copies of prescriptions. It also recommends discussing timing across time zones and storage with a healthcare professional. Ask for instructions specific to your itinerary and products, including what to do if the departure time changes.
Review the instructions in plain language with the prescriber or pharmacist. If you need an interpreter or accessible written format, arrange that before travel day. Ask them to distinguish ordinary schedule planning from situations in which you should seek clinical advice. This guide does not supply a universal dosing schedule.
Keep the agreed contact information accessible during the journey. If a companion is helping, decide what information they need and what tasks they can reasonably undertake. They should know how to contact appropriate help without being expected to make medication decisions themselves.
Plan the return supply before discharge
Ask the overseas team to review the return itinerary and the intended home prescribing arrangement before issuing discharge medication. Identify any new or changed medicine early enough to check the relevant rules and discuss follow-up. A last-day prescription can create avoidable uncertainty if the home clinician has not seen the plan.
Request a clear discharge medication list, reasons for changes, relevant results, and the next review date. Ask the local clinician whether they have received the information and what assessment they need before taking over. The guide to local follow-up after overseas treatment connects this step with appointments and continuing support.
Clarify what happens if the return date moves. A delay can affect supplies, permissions, monitoring, and booked appointments at once. Contact the responsible teams rather than assuming that an earlier plan automatically extends. Keep the updated instructions together and mark which version replaces the old one.
Use a final review to expose unanswered questions
Before departure, read the plan as if you were arriving at an unfamiliar clinic: which medicines are current, who will prescribe, where will supplies come from, and what happens if something is unavailable? Ask the teams to resolve any answer that still depends on “probably” or “usually.”
Medication continuity is supported by accurate records, lawful arrangements, and named clinical responsibility. The purpose of preparation is to preserve access to appropriate care through the journey and the return, with decisions made by the professionals and authorities responsible for them.
Sources and further reading
Found a detail that has changed? Tell the editorial team.